地塞米松与布地奈德雾化吸入治疗小儿急性感染性喉炎的效果及安全性分析  

Effect and safety analysis of dexamethasone and Budesonide aerosol inhalation in the treatment of acut e infectious laryngitis in children

作　　者：梁明 Liang Ming(Jilin City People’s Hospital,Jilin,132000,China)

机构地区：[1]吉林市人民医院,吉林吉林132000

出　　处：《中国医学文摘（耳鼻咽喉科学）》2024年第3期31-33,共3页Chinese Medical Digest(Otorhinolaryngology)

摘　　要：目的分析小儿AIL(急性感染性喉炎)患儿应用地塞米松和布地奈德雾化吸入治疗的效果及安全性。方法纳入我院2020年11月-2021年12月60例小儿急性感染性喉炎患儿为观察对象;随机分为两组各30例,1组应用地塞米松雾化吸入治疗的对比组,1组为应用布地奈德雾化吸入治疗的观察组;比较2组治疗效果。结果观察组病症消失时间显著更早,不良反应发生率及治疗后机体炎症水平因子显著更低(P<0.05)。结论布地奈德雾化吸入治疗小儿急性感染性喉炎效果显著,值得借鉴。Objective To analyze the efficacy and safety of inhalation of dexamethasone and budesonide in children with AIL(acute infectious laryngitis).Methods Sixty children with acute infectious laryngitis in our hospital from November 2020 to December 2021 were included as the observation objects.The patients were randomly divided into two groups of 30,1 group was the comparison group of dexamethasone inhalation treatment,and the other group was the observation group of budesonide inhalation treatment.The therapeutic effect of the two groups was compared.Results In the observation group,the time of disease disappearance was significantly earlier,and the incidence of adverse reactions and inflammatory factors after treatment were significantly lower(P<0.05).Conclusion Budesonide aerosol inhalation is effective in the treatment of acute infectious laryngitis in children.

关 键 词：小儿AIL(急性感染性喉炎) 地塞米松 布地奈德 雾化吸入 

分 类 号：R72[医药卫生—儿科]